Published in J Androl on September 04, 2008
Risks and benefits of testosterone therapy in older men. Nat Rev Endocrinol (2013) 2.47
Testosterone replacement therapy in patients with prostate cancer after radical prostatectomy. J Urol (2013) 1.90
A practical guide to male hypogonadism in the primary care setting. Int J Clin Pract (2010) 1.90
Elevated levels of gonadotrophins but not sex steroids are associated with musculoskeletal pain in middle-aged and older European men. Pain (2011) 1.41
Testosterone deficiency, insulin resistance and the metabolic syndrome. Nat Rev Endocrinol (2009) 1.30
Hypogonadism in the aging male diagnosis, potential benefits, and risks of testosterone replacement therapy. Int J Endocrinol (2012) 1.18
Osteoporosis in men: the value of laboratory testing. Osteoporos Int (2010) 0.95
The treatment of late-onset hypogonadism. Turk J Urol (2014) 0.84
The influence of age on bioavailable and free testosterone is independent of body mass index and glucose levels. World J Urol (2011) 0.84
The practical management of testosterone deficiency in men. Nat Rev Urol (2015) 0.83
Controversies in testosterone replacement therapy: testosterone and cardiovascular disease. Asian J Androl (2015) 0.82
Effect of long-acting testosterone undecanoate treatment on quality of life in men with testosterone deficiency syndrome: a double blind randomized controlled trial. Asian J Androl (2012) 0.82
Autophagic deficiency is related to steroidogenic decline in aged rat Leydig cells. Asian J Androl (2011) 0.81
Population-based patterns of prescription androgen use, 1976-2008. Pharmacoepidemiol Drug Saf (2014) 0.79
Risk Factors for Hypogonadism in Male Patients with Type 2 Diabetes. J Diabetes Res (2016) 0.78
Identification of late-onset hypogonadism in middle-aged and elderly men from a community of China. Asian J Androl (2016) 0.78
Andrology: Identifying late-onset hypogonadism in older men. Nat Rev Urol (2010) 0.78
An old emperor finds new clothing: rejuvenation in our time. Asian J Androl (2010) 0.77
Testosterone treatment of older men--why are controversies created? J Clin Endocrinol Metab (2011) 0.77
Aging and Sex Hormones in Males. Virulence (2016) 0.76
Androgen receptor agonism promotes an osteogenic gene program in preadipocytes. Biochem Biophys Res Commun (2013) 0.76
Waist-to-height ratio as a predictor of serum testosterone in ageing men with symptoms of androgen deficiency. Asian J Androl (2011) 0.76
Serum Testosterone (T) Level Variability in T Gel-Treated Older Hypogonadal Men: Treatment Monitoring Implications. J Clin Endocrinol Metab (2015) 0.76
Testosterone replacement therapy and the risk of prostate cancer. Asian J Androl (2015) 0.75
Testosterone level and mortality in elderly men with systolic chronic heart failure. Asian J Androl (2011) 0.75
Low serum testosterone is associated with tumor aggressiveness and poor prognosis in prostate cancer. Oncol Lett (2017) 0.75
Mendelian randomization: loosening the Gordian knot of testosterone and male ageing. Asian J Androl (2013) 0.75
Testosterone deficiency in the aging male. Ther Adv Urol (2016) 0.75
Challenges to treat hypogonadism in prostate cancer patients: implications for endocrinologists, urologists and radiotherapists. Transl Androl Urol (2015) 0.75
A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab (1999) 10.64
Bilateral orchiectomy with or without flutamide for metastatic prostate cancer. N Engl J Med (1998) 6.84
Treatment of muscle-invasive and metastatic bladder cancer: update of the EAU guidelines. Eur Urol (2011) 5.59
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol (2008) 5.56
Incidence and treatment of complications of bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol (1992) 4.79
A method for producing specific antisera with small doses of immunogen. J Clin Endocrinol Metab (1971) 4.38
Intracavitary Bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol (1976) 4.37
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol (2011) 4.25
Human Y chromosome azoospermia factors (AZF) mapped to different subregions in Yq11. Hum Mol Genet (1996) 3.78
Disease-specific survival following routine prostate cancer screening by digital rectal examination. JAMA (1993) 3.41
Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem (1993) 2.94
Mutation in the follicle-stimulating hormone receptor gene causes hereditary hypergonadotropic ovarian failure. Cell (1995) 2.89
Lifespan and testosterone. Nature (1993) 2.84
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study. J Urol (2001) 2.83
Biological actions of androgens. Endocr Rev (1987) 2.81
Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab (1997) 2.71
A sex difference in the human brain and its relation to transsexuality. Nature (1995) 2.64
Severe impairment of spermatogenesis in mice lacking the CREM gene. Nature (1996) 2.63
Failure to diagnose and treat osteoporosis in elderly patients hospitalized with hip fracture. Am J Med (2000) 2.62
Investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male (2005) 2.60
Sarcopenia: its assessment, etiology, pathogenesis, consequences and future perspectives. J Nutr Health Aging (2008) 2.54
Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione. J Biol Chem (1997) 2.53
The I.A.N.A Task Force on frailty assessment of older people in clinical practice. J Nutr Health Aging (2008) 2.53
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50
The follicle-stimulating hormone receptor: biochemistry, molecular biology, physiology, and pathophysiology. Endocr Rev (1997) 2.44
Predictors of skeletal muscle mass in elderly men and women. Mech Ageing Dev (1999) 2.39
Episodic variations of prolactin, thyroid-stimulating hormone, luteinizing hormone, melatonin and cortisol in infertile women with subclinical hypothyroidism. Hum Reprod (1997) 2.23
Thromboembolic phenomena after ovarian stimulation with human gonadotrophins. Lancet (1965) 2.15
Effect of aging on body fat. J Am Geriatr Soc (1993) 2.14
Current status of the molecular diagnosis of Y-chromosomal microdeletions in the work-up of male infertility. Initiative for international quality control. Hum Reprod (1998) 2.10
Serum testosterone levels are not elevated in patients with ankylosing spondylitis. J Rheumatol (1998) 2.09
Future trends in infertility treatment: challenges ahead. Fertil Steril (1997) 2.07
Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05
Commissary tobacco sales: the elimination of a historic artifact. Mil Med (1995) 2.00
Transsexualism: a review of etiology, diagnosis and treatment. J Psychosom Res (1999) 2.00
Creatine kinase activity in human spermatozoa and seminal plasma lacks predictive value for male fertility in in vitro fertilization. Fertil Steril (1998) 1.98
Prediction of ovulation by urinary hormone measurements with the home use ClearPlan Fertility Monitor: comparison with transvaginal ultrasound scans and serum hormone measurements. Hum Reprod (2000) 1.96
Treatment of rheumatoid arthritis with oral type II collagen. Results of a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (1998) 1.93
Evaluation of the cytokines interleukin 8 and epithelial neutrophil activating peptide 78 as indicators of inflammation in prostatic secretions. Urology (2000) 1.92
The Menopause Rating Scale (MRS): reliability of scores of menopausal complaints. Climacteric (2000) 1.91
Mortality and morbidity in transsexual subjects treated with cross-sex hormones. Clin Endocrinol (Oxf) (1997) 1.90
Diagnosis and therapeutic management of 18 patients with prostatic abscess. Urology (1999) 1.87
The teaching of legal medicine in British medical schools. Med Educ (1986) 1.87
Polypharmacy and hospitalization among older home care patients. J Gerontol A Biol Sci Med Sci (2000) 1.84
EAU guidelines on male infertility. Eur Urol (2005) 1.82
Rapid detection of bladder cancer: a comparative study of point of care tests. J Urol (1997) 1.80
Late-onset hypogonadism and mortality in aging men. J Clin Endocrinol Metab (2013) 1.77
Urine uric acid to creatinine rtio--a screening test for inherited disorders of purine metabolism. Phosphoribosyltransferase (PRT) deficiency in X-linked cerebral palsy and in a variant of gout. J Pediatr (1968) 1.76
Neuropeptide Y: a potent inducer of consummatory behavior in rats. Peptides (1985) 1.75
Increased expression of arginase II in human diabetic corpus cavernosum: in diabetic-associated erectile dysfunction. Biochem Biophys Res Commun (2001) 1.74
Controlled trial of a geriatric case-finding and liaison service in an emergency department. J Am Geriatr Soc (1996) 1.72
Towards less confusing terminology in reproductive medicine: a proposal. Hum Reprod (2004) 1.70
Dietary supplement use in the Prostate Cancer Prevention Trial: implications for prevention trials. Nutr Cancer (2001) 1.69
The primary care physician and Alzheimer's disease: an international position paper. J Nutr Health Aging (2010) 1.68
Oxybutynin in bladder spasm, neurogenic bladder, and enuresis. Urology (1976) 1.67
Predictors of immediate and 6-month outcomes in hospitalized elderly patients. The importance of functional status. J Am Geriatr Soc (1988) 1.66
External quality control in the andrology laboratory: an experimental multicenter trial. Fertil Steril (1990) 1.65
Overview of the MNA--Its history and challenges. J Nutr Health Aging (2006) 1.65
Testicular sperm extraction in a patient with metachronous bilateral testicular cancer. Hum Reprod (2001) 1.63
Impotence in medical clinic outpatients. JAMA (1983) 1.63
Race, treatment, and long-term survival from prostate cancer in an equal-access medical care delivery system. JAMA (1995) 1.62
The Menopause Rating Scale (MRS): comparison with Kupperman index and quality-of-life scale SF-36. Climacteric (2000) 1.62
Antioxidant treatment of patients with asthenozoospermia or moderate oligoasthenozoospermia with high-dose vitamin C and vitamin E: a randomized, placebo-controlled, double-blind study. Hum Reprod (1999) 1.61
Enzymatic radioiodination of gonadotropins. J Clin Endocrinol Metab (1972) 1.61
Thyroxine concentration in human milk. J Clin Endocrinol Metab (1977) 1.61
Ovarian response to follicle-stimulating hormone (FSH) stimulation depends on the FSH receptor genotype. J Clin Endocrinol Metab (2000) 1.60
Male-to-female transsexuals have female neuron numbers in a limbic nucleus. J Clin Endocrinol Metab (2000) 1.60
Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial. Arthritis Rheum (2001) 1.58
Chronic widespread pain is associated with slower cognitive processing speed in middle-aged and older European men. Pain (2010) 1.58
Role of oxidative stress and antioxidants in male infertility. J Androl (1997) 1.58
Unrecognized delirium in ED geriatric patients. Am J Emerg Med (1995) 1.56
Investigation, treatment and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA and ASA recommendations. Eur J Endocrinol (2008) 1.55